QCG
CDMO

Quadrant Capital Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Quadrant Capital Group’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-222
Closed -$2.74K – 2864
2024
Q4 		$2.74K Hold
222
– – ﹤0.01% 2450
2024
Q3 		$2.53K Hold
222
– – ﹤0.01% 2455
2024
Q2 		$1.59K Buy
222
+152
+217% +$1.16K ﹤0.01% 2510
2024
Q1 		$469 Sell
70
-424
-86% -$2.92K ﹤0.01% 2645
2023
Q4 		$3.21K Buy
494
+456
+1,200% +$2.94K ﹤0.01% 2379
2023
Q3 		$359 Sell
38
-82
-68% -$987 ﹤0.01% 2616
2023
Q2 		$1.68K Sell
120
-70
-37% -$1.19K ﹤0.01% 2447
2023
Q1 		$3.56K Buy
190
+70
+58% +$1.15K ﹤0.01% 2304
2022
Q4 		$1.65K Buy
120
+103
+606% +$1.58K ﹤0.01% 2465
2022
Q3 		$0 Buy
+17
New +$310 ﹤0.01% 2836

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Quadrant Capital Group's CDMO Position: Q1 2025 in Review

Quadrant Capital Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 222 shares — an estimated $2.74K sold.

Quadrant Capital Group first reported a position in CDMO in Q3 2022 and held it in 10 quarters. The position peaked at $3.56K in Q1 2023. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Quadrant Capital Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Quadrant Capital Group sold 222 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $2.74K.
  • Quadrant Capital Group first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2022 and held it in 10 quarters.
  • Quadrant Capital Group's Avid Bioservices, Inc. Common Stock position peaked at $3.56K in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Quadrant Capital Group's 13F filing for Q1 2025, filed 13 May 2025.